Amgen

FDA may limit anemia drug use for kidney disease
Yahoo/AP
Thu, 10/14/10 - 11:03 am
anemia
kidney disease
FDA
Amgen
Procrit
Aranesp
Epogen
Is Gilead Sciences a Sell?
Motley Fool
Thu, 10/14/10 - 09:32 am
Gilead Sciences
Amgen
Celgene
Genzyme
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer
Yahoo/PR Newswire
Sun, 10/10/10 - 11:55 am
AMG 386
Amgen
paclitaxel
ovarian cancer
Actelion Surges on Report It May Be Weighing Selling Itself
Bloomberg
Fri, 10/8/10 - 08:09 am
Actelion
M&A
GSK
Roche
Amgen
Bristol-Myers Squibb
FDA delays ruling on Teva version of Amgen drug
Yahoo/AP
Fri, 10/1/10 - 12:16 pm
Teva Pharmaceuticals
FDA
neutropenia
generics
Amgen
Neupogen
Amgen Drug May Block Some Breast Cancer, Studies Hint
Bloomberg
Thu, 09/30/10 - 11:24 am
Amgen
breast cancer
denosumab
Good News for Hospira
Yahoo/Zacks.com
Mon, 09/27/10 - 12:01 pm
Nivestem
Hospira
biosimilars
Amgen
Amgen recalls anemia drugs due to glass flakes
Yahoo/AP
Fri, 09/24/10 - 11:14 am
Amgen
anemia
recalls
Epogen
Procrit
Savient Investors Expect a Sale
TheStreet.com
Wed, 09/15/10 - 08:06 am
Savient
M&A
gout
FDA
Krystexxa
JNJ
Pfizer
Amgen
Novartis
Bristol-Myers Squibb
Genzyme Cuts Back for Future Gains: Biotechs Must Revert to Lean Growth
Seeking Alpha
Wed, 09/15/10 - 07:37 am
layoffs
biotech
Genzyme
Amgen
Biogen Idec
Celgene
Gilead Sciences
Sanofi
Amgen Plans to Sell $1.5 Billion of Bonds in Second Debt Offering of 2010
Bloomberg
Tue, 09/14/10 - 08:07 am
Amgen
bonds
The One Thing You Must Know About Amgen
Motley Fool
Fri, 09/10/10 - 09:33 am
Amgen
Kevin Sharer
Pharma CEOs
'Multiple Shrinkage' Weighs on Large-Cap Biotech
TheStreet.com
Tue, 09/7/10 - 01:12 pm
biotech
Amgen
Celgene
Biogen Idec
Gilead Sciences
Genzyme
Does Amgen Pass Buffett's Test?
Motley Fool
Fri, 09/3/10 - 08:03 am
Warren Buffett
Amgen
Why Amgen Should Buy Genzyme
Forbes
Tue, 08/31/10 - 01:03 pm
Amgen
M&A
Genzyme
Sanofi
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb
Could Amgen Be a Multibagger?
Motley Fool
Tue, 08/24/10 - 01:09 pm
Amgen
How Well Do You Use Cash, Amgen?
Motley Fool
Mon, 08/23/10 - 05:32 pm
Amgen
Biogen Idec
Genzyme
Big Pharma's Top 5 Emerging Market Deals
Fierce Pharma
Mon, 08/23/10 - 10:32 am
emerging markets
Abbott Laboratories
Piramal Healthcare
India
GSK
Laboratorios Phoenix
Argentina
Novartis
China
Zhejiang Tianyuan Bio-Pharmaceutical
Brazil
Amgen
South Korea
Dong-A Pharma
Dividends Aren't Enough: Biotech
Motley Fool
Sat, 08/21/10 - 10:48 am
Gilead Sciences
Amgen
Genzyme
Dendreon
Biogen Idec

Pages